PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1843
https://www.valueinhealthjournal.com/article/S1098-3015(23)01943-5/fulltext
Title :
PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01943-5&doi=10.1016/j.jval.2023.03.1843
First page :
Section Title :
Open access? :
No
Section Order :
11164